Calidi Biotherapeutics (CLDI) Announces 1:10 Reverse Share Split

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. SBUX
3. LEVI
4. HUM
5. NVDA
6. CMG
7. ALHC
8. STZ
9. AAPL
10. SPY

Go back to Calidi Biotherapeutics (CLDI) Announces 1:10 Reverse Share Split

Calidi to Effect Reverse Stock Split

July 5, 2024 4:15 PM EDT

Calidi common stock expected to begin trading on a 1-for-10 split adjusted basis on July 15, 2024

SAN DIEGO--(BUSINESS WIRE)-- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (Calidi or Company), a clinical-stage biotechnology company developing a new generation of targeted virotherapies, today announced that its Board of Directors has approved the reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10 (the Reverse Stock Split). The Reverse Stock Split is expected to become effective at 12:01 a.m. Eastern Time on July 15, 2024. The Companys... More